Kintara Therapeutics Statistics
Share Statistics
Kintara Therapeutics has 55.66M
shares outstanding. The number of shares has increased by 0.64%
in one year.
| Shares Outstanding | 55.66M |
| Shares Change (YoY) | 0.64% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 4.76% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 95,247 |
| FTD / Avg. Volume | 114.22% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -3.23 and the forward
PE ratio is null.
Kintara Therapeutics's PEG ratio is
0.05.
| PE Ratio | -3.23 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 7.3 |
| P/FCF Ratio | -3.81 |
| PEG Ratio | 0.05 |
Financial Ratio HistoryEnterprise Valuation
Kintara Therapeutics has an Enterprise Value (EV) of 22.52M.
| EV / Sales | 0 |
| EV / EBITDA | -2.68 |
| EV / EBIT | -3.14 |
| EV / FCF | -3.13 |
Financial Position
The company has a current ratio of 2.45,
with a Debt / Equity ratio of 0.
| Current Ratio | 2.45 |
| Quick Ratio | 2.45 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is -226.27% and Return on Invested Capital is -228.29%.
| Return on Equity | -226.27% |
| Return on Assets | -137.07% |
| Return on Invested Capital | -228.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-8,501,000 |
| Employee Count | 1 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 76K |
| Effective Tax Rate | -0.89% |
Stock Price Statistics
The stock price has increased by -95.43% in the
last 52 weeks. The beta is 0.81, so Kintara Therapeutics's
price volatility has been higher than the market average.
| Beta | 0.81 |
| 52-Week Price Change | -95.43% |
| 50-Day Moving Average | 6.51 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 24.39 |
| Average Volume (20 Days) | 83,392 |
Income Statement
| Revenue | n/a |
| Gross Profit | -55K |
| Operating Income | -8.5M |
| Net Income | -8.5M |
| EBITDA | -8.4M |
| EBIT | -8.45M |
| Earnings Per Share (EPS) | -3.23 |
Full Income StatementBalance Sheet
The company has 4.91M in cash and 0 in
debt, giving a net cash position of 4.91M.
| Cash & Cash Equivalents | 4.91M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -159.88M |
| Total Assets | 6.2M |
| Working Capital | 3.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -7.18M
and capital expenditures -20K, giving a free cash flow of -7.2M.
| Operating Cash Flow | -7.18M |
| Capital Expenditures | -20K |
| Free Cash Flow | -7.2M |
| FCF Per Share | -2.73 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
